Effects of L-carnitine supplementation on glucolipid metabolism: a systematic review and meta-analysis.
Yanfei Li,Yuchen Xie,Chensheng Qiu,Bowen Yu,Fangzheng Yang,Yuanchao Cheng,Weizhen Zhong,Junhua Yuan
DOI: https://doi.org/10.1039/d2fo02930h
2023-01-30
Abstract:Background: L-carnitine supplementation has been utilized against glucolipid metabolism disruption. However, to the best of our knowledge, no meta-analysis had analyzed the effects of L-carnitine supplementation on insulin resistance, fasting blood glucose, lipid metabolism and liver enzyme levels in adults. Methods: Through analysis and screening of 12221 studies, 15 studies were selected from eligible trials for meta-analysis. Meta-analysis was performed in a random effects model, with heterogeneity determined by I2, and subgroup analyses were used to further identify the source of heterogeneity. Result: The results showed significant effects of L-carnitine on FBG (MD = -4.94 mg/dl, 95% CI: -7.07 to -2.82,), insulin ( MD = -0.99 μU/ml, 95% CI: -1.41 to -0.56), HOMA-IR ( MD = -0.58, 95% CI: -0.77 to -0.38), TG ( MD = -11.22 mg/dl, 95% CI: -19.21 to -3.22), TC ( MD = -6.45 mg/dL, 95% CI: -9.95 to -2.95), LDLc ( MD = -8.28 mg/dl, 95% CI: -11.08 to -5.47) and ALT ( MD = -19.71 IU/L, 95% CI: -36.45 to-2.96) . However, no significant effect of L-carnitine supplementation was observed in HDLc (MD = -0.77 mg/dl, 95% CI: -0.10 to -1.63) or AST (MD = -11.05 IU/L, 95% CI: -23.08 to 0.99). Duration of carnitine supplementation was negatively associated with mean differences in FBG as assessed by meta-regression. Conclusion: The current meta-analysis revealed that L-carnitine may have favorable effects on glucolipid profile, especially insulin, FBG, HOMA-IR, TG, TC, LDLc and ALT levels.
biochemistry & molecular biology,food science & technology